mTOR Inhibitors for Management of Encapsulating Peritoneal Sclerosis: A Review of Literatures

Renal Failure - United States
doi 10.1080/0886022x.2016.1209026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Encapsulating Peritoneal Sclerosis

CMAJ
Medicine
2009English

Encapsulating Peritoneal Sclerosis: Different Clinical Presentations and Their Management

Archives of Renal Diseases and Management
2017English

Case Report of a Patient Undergoing Peritoneal Dialysis With Encapsulating Peritoneal Sclerosis Superimposed With Calciphylaxis

Iranian Red Crescent Medical Journal
Medicine
2016English

Encapsulating Peritoneal Sclerosis Developed 11 Years After the Discontinuation of Peritoneal Dialysis: A Case Report

Nihon Toseki Igakkai Zasshi
2003English

Phenotypes of Encapsulating Peritoneal Sclerosis--Macroscopic Appearance, Histologic Findings, and Outcome

Peritoneal Dialysis International
MedicineNephrology
2013English

Encapsulating Peritoneal Sclerosis in Incident PD Patients in Scotland

2011English

The Use of Home Parenteral Nutrition as a Treatment Option in Encapsulating Peritoneal Sclerosis

Proceedings of the Nutrition Society
MedicineNutritionDietetics
2010English

Successful Treatment of Encapsulating Peritoneal Sclerosis by Hemodialysis and Peritoneal Lavage Using Dialysate Containing Dissolved Hydrogen

Peritoneal Dialysis International
MedicineNephrology
2015English

Encapsulating Peritoneal Sclerosis in a Patient After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

BMC Gastroenterology
MedicineGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy